Custom-Made AAV was used for gene over-expression. (From
BrainVTA)
The viruses used in this article from BrainVTA are in the table below
Custom-Made AAV |
pAAV-cTnT-MCS-P2A-EGFP
pAAV-cTnT-CNTF-P2A-EGFP |
Peng Zhong, Gaofeng Zeng, ChangCheng Lei, Guoping Tian, Shao Ouyang, Fangyao Liu, Jianye Peng
Pub Date: 2021-02-12,
DOI: 10.1016/j.bbrc.2021.01.111,
Email: sales@brainvta.com
Background: Ciliary neurotrophic factor (CNTF), which is a neural peptide, has been reported to confer cardioprotective effects. However, whether CNTF-based gene therapy could prevent cardiac remodelling remains incompletely clear. In this study, we used adeno-associated viral vector serotype 9 (AAV9)-based cardiac gene therapy to test the effects of CNTF overexpression on adverse ventricular remodelling in angiotensin II (Ang II)-infused mice.
Methods: First, AAV9-EGFP and AAV9-CNTF constructs were generated with virus concentration at 5×1012 vg/ml. Next, postnatal (P3eP10) mice with C57BL/6J background were administered with 5×1011 vg of AAV9 recombinant genome diluted in 50 l of saline, and delivered through intraperitoneal injection. Implantation of osmotic minipumps was performed in 8-week-old male mice and human Ang II solution was administrated in the mice subcutaneously for 14 days through the pumps. Finally, we evaluated the effects of CNTF overexpression on mouse cardiac function, hypertrophy and fibrosis, as well as investigated the possible mechanisms.
Results: Our data showed that CNTF overexpression in mouse cardiomyocytes prevents cardiac hypertrophy and fibrosis induced by chronic Ang II stimulation. Mechanistic study found that CNTF overexpression upregulated NFE2-related factor 2 (Nrf2) antioxidant pathway, coupled with decreased ROS level in the cardiac tissues. Additionally, inflammatory cytokines were found to be reduced upon cardiac CNTF overexpression in response to chronic Ang II stimulation.
Conclusions: Altogether, these results provide further evidence that CNTF can alleviate the condition of cardiac remodelling induced by chronic Ang II stimulation. Therefore, our results suggest a potential therapeutic role of CNTF in cardiac pathological remodelling.
Figure 1. Evaluation of target gene expression delivered through peritoneal injection of mice with AAV9.
In the present study, the authors elucidated the cardioprotective effects of CNTF in pathological cardiac remodelling induced by 2 weeks of Ang II infusion through adeno-associated viral vector serotype 9 (AAV9)-mediated CTNF overexpression. The results showed that the specific overexpression of CNTF in cardiomyocytes could exert cardioprotective effects in response to chronic Ang II stimulation mainly through the regulation of both oxidative stress pathway and inflammatory pathway.
BrainVTA offers viral vector construction & virus packaging services for AAV, LV, RABV, PRV, HSV and VSV that help researchers explore questions about genes, neurons, circuitry structure, function of brain network, mechanism and treatment of diseases.
If you have any needs, just email us at
sales@brainvta.com.